A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 450 participants.

Also called NCT01193179

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 450 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01193179
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01193179. Allocation not applicable; no masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2012-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
Condition
Diabetes, Type 2
Intervention (Drug)
OPC-262
Lead sponsor
Kyowa Kirin Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct01193179
Content hash
cf4a28968c3cc21992fa9355b0d44f7d0f1a3f07effa72980b2fbebea8072253